Our results suggest CHI3L2 expression has strong correlations with marker sets, include CD86 and CSF1R of monocytes, CCL2, CD68, and IL 10 of TAMs and CD163, VSIG4, and MS4A4A of M2 macrophages in GBM and LGG. The gene discussed is CD163; the disease is glioblastoma.